These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 15974913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA.
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA, Gu Z, Nakamura T.
    Int Rev Neurobiol; 2007 Dec; 82():1-27. PubMed ID: 17678953
    [Abstract] [Full Text] [Related]

  • 6. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS, Lipton SA.
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [Abstract] [Full Text] [Related]

  • 7. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK, Kaul CL, Ramarao P.
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [Abstract] [Full Text] [Related]

  • 8. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA, Wenk GL.
    CNS Drug Rev; 2003 Jan; 9(3):275-308. PubMed ID: 14530799
    [Abstract] [Full Text] [Related]

  • 9. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.
    Lipton SA.
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S38-46. PubMed ID: 12852433
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.
    Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.
    Curr Alzheimer Res; 2012 Jul; 9(6):746-58. PubMed ID: 21875407
    [Abstract] [Full Text] [Related]

  • 12. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA.
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [Abstract] [Full Text] [Related]

  • 13. Management of moderate to severe Alzheimer's disease: focus on memantine.
    Dominguez E, Chin TY, Chen CP, Wu TY.
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):415-23. PubMed ID: 22212311
    [Abstract] [Full Text] [Related]

  • 14. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias.
    Molinuevo JL, Lladó A, Rami L.
    Am J Alzheimers Dis Other Demen; 2005 Dec; 20(2):77-85. PubMed ID: 15844753
    [Abstract] [Full Text] [Related]

  • 15. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM.
    Psychopharmacol Bull; 2003 Dec; 37(2):41-9. PubMed ID: 14566213
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of memantine.
    Johnson JW, Kotermanski SE.
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [Abstract] [Full Text] [Related]

  • 17. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
    Farlow MR.
    Geriatrics; 2004 Jun; 59(6):22-7. PubMed ID: 15224791
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL, Lladó Plarrumaní A.
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [Abstract] [Full Text] [Related]

  • 19. Classics in Chemical Neuroscience: Memantine.
    Alam S, Lingenfelter KS, Bender AM, Lindsley CW.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):1823-1829. PubMed ID: 28737885
    [Abstract] [Full Text] [Related]

  • 20. NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer's and vascular dementia.
    Koch HJ, Szecsey A, Haen E.
    Curr Pharm Des; 2004 Sep 20; 10(3):253-9. PubMed ID: 14754385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.